Home

Neil Desai

CIK 1878692 · EXECUTIVE CHAIRMAN · last filed 2026-06-15

Neil Desai is an EXECUTIVE CHAIRMAN who has filed 34 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for WHWK, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

34

Lifetime Open-Market Net

-$3.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WHWK Director — $4.47 — $0 2 2026-06-15
Whitehawk Therapeutics, Inc. (AADI) Delisted EXECUTIVE CHAIRMAN 639,698 $2.05 $1.31M -$3.01M 26 2024-09-05

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 WHWK Grant (A) — $0 EDGAR
2025-06-17 WHWK Grant (A) — $0 EDGAR
2024-09-05 Whitehawk Therapeutics, Inc. (AADI) Delisted Sell (S) −40,000 -$68.3K EDGAR
2024-09-03 WHWK Notice (144) −120,000 -$214.4K EDGAR
2024-08-05 Whitehawk Therapeutics, Inc. (AADI) Delisted Sell (S) −40,000 -$57.4K EDGAR
2024-07-02 Whitehawk Therapeutics, Inc. (AADI) Delisted Sell (S) −40,000 -$57.2K EDGAR
2024-06-05 Whitehawk Therapeutics, Inc. (AADI) Delisted Sell (S) −40,000 -$71.5K EDGAR
2024-06-03 WHWK Notice (144) −120,000 -$220.0K EDGAR
2024-05-01 Whitehawk Therapeutics, Inc. (AADI) Delisted Sell (S) −40,000 -$77.2K EDGAR
2024-04-03 Whitehawk Therapeutics, Inc. (AADI) Delisted Sell (S) −40,000 -$90.6K EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.